The CASZ1/Egfl7 transcriptional pathway is required for RhoA expression in vascular endothelial cells
暂无分享,去创建一个
[1] Hao Zhou,et al. Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/myocardin-related transcription factor--a signaling pathway. , 2013, The international journal of biochemistry & cell biology.
[2] F. Conlon,et al. Transcriptional regulation of blood vessel formation: The role of the CASZ1/Egfl7/RhoA pathway , 2013, Cell cycle.
[3] R. Adams,et al. G13 controls angiogenesis through regulation of VEGFR-2 expression. , 2013, Developmental cell.
[4] F. Conlon,et al. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway. , 2013, Developmental cell.
[5] E. Chavakis,et al. EGFL7 ligates αvβ3 integrin to enhance vessel formation. , 2013, Blood.
[6] Xiaoping Du,et al. Inside-out, outside-in, and inside-outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction. , 2012, Current opinion in cell biology.
[7] Hiroshi I. Suzuki,et al. TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. , 2012, Journal of biochemistry.
[8] I. Geudens,et al. Coordinating cell behaviour during blood vessel formation , 2011, Development.
[9] S. Patel-Hett,et al. Signal transduction in vasculogenesis and developmental angiogenesis. , 2011, The International journal of developmental biology.
[10] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[11] Diana C. Chong,et al. Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. , 2011, Developmental cell.
[12] Y. Noda,et al. Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions , 2011, Journal of The Royal Society Interface.
[13] Yi Zheng,et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. , 2011, Cancer letters.
[14] J. Khan,et al. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression , 2011, Cell Death and Differentiation.
[15] H. Stuhlmann,et al. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7. , 2010, Blood.
[16] J. Liao,et al. RhoA/ROCK signaling is essential for multiple aspects of VEGF‐mediated angiogenesis , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] J. Waschke,et al. Role of GTPases in control of microvascular permeability. , 2010, Cardiovascular research.
[18] T. Ogihara,et al. Blood Pressure and Hypertension Are Associated With 7 Loci in the Japanese Population , 2010, Circulation.
[19] P. Pandolfi,et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis , 2010, Nature Cell Biology.
[20] R. Weinberg,et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. , 2009, Genes & development.
[21] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[22] T. Wirth,et al. Myc Regulates Embryonic Vascular Permeability and Remodeling , 2009, Circulation research.
[23] Stephan Huveneers,et al. Adhesion signaling – crosstalk between integrins, Src and Rho , 2009, Journal of Cell Science.
[24] Domenico Coppola,et al. MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.
[25] Anne J. Ridley,et al. Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.
[26] A. Paradiso,et al. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. , 2008, International journal of molecular medicine.
[27] F. Soncin,et al. VE‐statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases , 2008, The EMBO journal.
[28] M. L. King,et al. A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development , 2008, Development.
[29] F. Conlon,et al. Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline. , 2008, Developmental cell.
[30] R. Treisman,et al. RPEL Motifs Link the Serum Response Factor Cofactor MAL but Not Myocardin to Rho Signaling via Actin Binding , 2007, Molecular and Cellular Biology.
[31] H. Kuwano,et al. Clinical and Prognostic Significance of RhoA and RhoC Gene Expression in Esophageal Squamous Cell Carcinoma , 2007, Annals of Surgical Oncology.
[32] C. Croce,et al. MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.
[33] C. Thiele,et al. Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation. , 2006, Biochemical and biophysical research communications.
[34] P. Opolon,et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] Joan M. Taylor,et al. Sphingosine 1-Phosphate Stimulates Smooth Muscle Cell Differentiation and Proliferation by Activating Separate Serum Response Factor Co-factors* , 2004, Journal of Biological Chemistry.
[36] L. Campagnolo,et al. Egfl7, a novel epidermal growth factor‐domain gene expressed in endothelial cells , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[37] Didier Y. R. Stainier,et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation , 2004, Nature.
[38] T. Nikaido,et al. Up-Regulation of Small GTPases, RhoA and RhoC, Is Associated with Tumor Progression in Ovarian Carcinoma , 2003, Laboratory Investigation.
[39] R. Treisman,et al. Actin Dynamics Control SRF Activity by Regulation of Its Coactivator MAL , 2003, Cell.
[40] John L Cleveland,et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.
[41] A. Ridley,et al. Intercellular Adhesion Molecule (ICAM)-1, But Not ICAM-2, Activates RhoA and Stimulates c-fos and rhoA Transcription in Endothelial Cells1 , 2002, The Journal of Immunology.
[42] J. Campos-Ortega,et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. , 2001, Development.
[43] Sybill Patan,et al. Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling , 2000, Journal of Neuro-Oncology.
[44] B. Kaina,et al. Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.
[45] A. Bradley,et al. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. , 1993, Genes & development.
[46] C. Doe,et al. ming is expressed in neuroblast sublineages and regulates gene expression in the Drosophila central nervous system. , 1992, Development.
[47] W. Odenwald,et al. castor encodes a novel zinc finger protein required for the development of a subset of CNS neurons in drosophila , 1992, Neuron.
[48] V. Bautch,et al. Vascular development: genetic mechanisms and links to vascular disease. , 2010, Current topics in developmental biology.
[49] K. Plate,et al. Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal , 2009, Nature Cell Biology.
[50] S. Narumiya,et al. Use and properties of ROCK-specific inhibitor Y-27632. , 2000, Methods in enzymology.